辛辛那提8090lu.com

中医药研究院导师介绍导师姓名冯宇新性别男职称研究员出生年月1968.
10导师类别硕导导师学位博士联系电话15822005360E-mailFengyn2016@163.
com招生要求研究方向造血干细胞移植,中西医结合防治移植物抗宿主病,中药免疫药理学简介冯宇新生于中国天津市,1990毕业于青岛海洋大学(中国海洋大学)生物学专业,1997年获得南开大学分子生物学硕士学位,2007年获得美国辛辛那提大学(UniversityofCincinnati)细胞和癌症生物学博士学位,部分研究成果发表于美国国家科学院院报(PNAS).
2008-09年任美国加州博尔诚公司细胞与分子生物学首席研究员,2009-12年担任美国辛辛那提儿童医院医学中心博士后,2013-14任美国辛辛那提儿童医院医学中心研究员,2014-16年任美国密西根波普医疗系统成人造血干细胞实验室研究员.
科研项目:1.
CancerFreeKids(Cincinnati,OH,USA),针对骨髓微环境治疗急性白血病(Targetingbonemarrownichetoeradicatechildhoodacutemyeloidleukemia(AML)),2013/06-2014/06,$25,000,已结题,主持2.
中国江苏省科委,CD133阳性内皮前体细胞的工业化制备,2011/07-2013/07,200万元人民币,已结题,主持3.
NIHtraininggrantatUniversityofCincinnati:TheroleofCdc42inbonemarrowendothelialcellsandhematopoiesis(PI)2009/12-2012/12;已结题,主持4.
基因泰克制药公司和博尔诚公司科研项目(GenentechPharmaceutical&BioChainInstituteInc.
CA,USA):建立小鼠骨髓内皮细胞原代培养的新方法(NovelMethodtoestablishmurinebonemarrowendothelialprimaryculture),2008/10-2009/10,已结题,主持论文:XiaoM,YangJ,FengY,ZhuY,ChaiX,WangY.
Metaproteomicstrategiesandapplicationsforgutmicrobialresearch.
ApplMicrobiolBiotechnol.
2017Mar14.
doi:10.
1007/s00253-017-8215-7.
[Epubaheadofprint]Review.
PubMedPMID:28293710.
Al-HomsiAS,GoodykeA,McLaneM,Abdel-MageedS,ColeK,MuilenburgM,FengY.
Post-TransplantationCyclophosphamideandIxazomibCombinationRescuesMiceSubjectedtoExperimentalGraft-versus-HostDiseaseandIsSuperiortoEitherAgentAlone.
BiolBloodMarrowTransplant.
2017Feb;23(2):255-261.
doi:10.
1016/j.
bbmt.
2016.
11.
015.
PubMedPMID:27888016.
Al-HomsiAS,GoodykeA,ColeK,MuilenburgM,McLaneM,Abdel-MageedS,FengY.
IxazomibSuppressesHumanDendriticCellandModulatesMurineGraft-Versus-HostDiseaseinaSchedule-DependentFashion.
ExpHematol.
2016Dec19.
pii:S0301-472X(16)30770-6.
doi:10.
1016/j.
exphem.
2016.
12.
002.
[Epubaheadofprint]PubMedPMID:28007655.
Al-HomsiAS,FengY,DuffnerU,AlMalkiMM,GoodykeA,ColeK,MuilenburgM,Abdel-MageedA.
Bortezomibforthepreventionandtreatmentofgraft-versus-hostdiseaseafterallogeneichematopoieticstemcelltransplantation.
ExpHematol.
2016Sep;44(9):771-7.
doi:10.
1016/j.
exphem.
2016.
05.
005.
Review.
PubMedPMID:27224851.
Al-HomsiAS,RoyTS,ColeK,FengY,DuffnerU.
Post-transplanthigh-dosecyclophosphamideforthepreventionofgraft-versus-hostdisease.
BiolBloodMarrowTransplant.
2015Apr;21(4):604-11.
doi:10.
1016/j.
bbmt.
2014.
08.
014.
Epub2014Aug23.
Review.
PubMedPMID:25240817CaoX,XuP,OyolaMG,XiaY,YanX,SaitoK,ZouF,WangC,YangY,HintonAJr,YanC,DingH,ZhuL,YuL,YangB,FengY,CleggDJ,KhanS,DiMarchiR,ManiSK,TongQ,XuY.
Estrogensstimulateserotoninneuronstoinhibitbinge-likeeatinginmice.
JClinInvest.
2014Aug26.
pii:74726.
doi:10.
1172/JCI74726.
[Epubaheadofprint]PubMedPMID:25157819.
FengYandZhengY.
OncogenicInsultInBoneMarrowEndothelialCellsCausesHematopoieticAbnormalities.
November15,2013;Blood:122(21):2461FengY,SingletonDW,GuoC,GardnerA,PakalaS,KumarR,JensenEV,ZhangJandKhanSA.
DNAhomologousrecombinationfactorSFR1physicallyandfunctionallyinteractswithestrogenreceptor.
PlosOneJuly2013.
http://www.
plosone.
org/article/info:doi/10.
1371/journal.
pone.
0068075FengY,ZouX,LiuW,GuoF,LiuM,SampsonL,YouL-R,KuanC-YandZhengY.
RhoGtpaseCdc42IsEssentialforEndothelialNicheMaintenanceintheBoneMarrowandHematopoiesis.
Blood(ASHAnnualMeetingAbstracts),Nov2012;120(21):508.
FengY,LiuM,GuoF,LiuW,SampsonL,YouL-R,KuanC-YandZhengY.
NovelMethodtoStudyMouseBoneMarrowEndothelialCellsinVivoandinVitro.
Blood.
Nov2012;120(21):617.
SipesNS,FengY,GuoF,LeeHO,ChouFS,ChengJ,MulloyJ,ZhengY.
Cdc42regulatesextracellularmatrixremodelinginthreedimensions.
JBiolChem.
2011Oct21;286(42):36469-77.
FengY,ZhouXandZhengY.
TheRhoGTPaseCdc42IsaKeyRegulatoroftheGenesisandFunctionofBoneMarrowDerivedEndothelial-LikeCells.
Blood.
Nov2010;116(21):2109.
LiuW,FengY,ShangX,ZhengY.
RhoGTPasesinhematopoieticstem/progenitorcellmigration.
MethodsMolBiol.
2011;750:307-19.
FengY,MankaD,WagnerKU,KhanSA.
Estrogenreceptor-alphaexpressioninthemammaryepitheliumisrequiredforductalandalveolarmorphogenesisinmice.
ProcNatlAcadSciUSA.
2007Sep11;104(37):14718-23.
SingletonDW,FengY,YangJ,PugaA,LeeAV,KhanSA.
Geneexpressionprofilingrevealsnovelregulationbybisphenol-Ainestrogenreceptor-alpha-positivehumancells.
EnvironRes.
2006Jan;100(1):86-92.
SingletonDW,FengY,ChenY,BuschSJ,LeeAV,PugaA,KhanSA.
Bisphenol-AandestradiolexertnovelgeneregulationinhumanMCF-7derivedbreastcancercells.
MolCellEndocrinol.
2004Jun30;221(1-2):47-55.
RanR,LuA,ZhangL,TangY,ZhuH,XuH,FengY,HanC,ZhouG,RigbyAC,SharpFR.
Hsp70promotesTNF-mediatedapoptosisbybindingIKKgammaandimpairingNF-kappaBsurvivalsignaling.
GenesDev.
2004Jun15;18(12):1466-81.
SingletonDW,FengY,BurdCJ,KhanSA.
Nongenomicactivityandsubsequentc-fosinductionbyestrogenreceptorligandsarenotsufficienttopromotedeoxyribonucleicacidsynthesisinhumanendometrialadenocarcinomacells.
Endocrinology.
2003Jan;144(1):121-8.
ValeriusMT,PattersonLT,FengY,PotterSS.
Hoxa11isupstreamofIntegrinalpha8expressioninthedevelopingkidney.
ProcNatlAcadSciUSA.
2002Jun11;99(12):8090-5.
LiuC,LiG,FengY,Shi,G,ChenY,andChenD.
CharacteristicsofthedeletionofintegratedgenesinducedbyinhibitorofPARP.
ActaScientiarumNaturaliumUniversityNankaiensis(NaturalScienceEdition).
200134(1):21-24.